• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地高辛药代动力学与多药耐药基因1(MDR1)基因多态性

Digoxin pharmacokinetics and MDR1 genetic polymorphisms.

作者信息

Verstuyft Céline, Schwab Mathias, Schaeffeler Elke, Kerb Reinhold, Brinkmann Ulrich, Jaillon Patrice, Funck-Brentano Christian, Becquemont Laurent

机构信息

Department of Pharmacology, Saint-Antoine Hospital, 184 rue du Faubourg Saint Antoine, 75012, Paris, France.

出版信息

Eur J Clin Pharmacol. 2003 Apr;58(12):809-12. doi: 10.1007/s00228-003-0567-5. Epub 2003 Mar 1.

DOI:10.1007/s00228-003-0567-5
PMID:12698307
Abstract

BACKGROUND

The effect of MDR1 C3435T single nucleotide polymorphism (SNP) in exon 26 on digoxin pharmacokinetics has recently been challenged. OBJECTIVE. To clarify the relationships between MDR1 genetic polymorphisms in exon 26 (C3435T) and 21 (G2677T/A) and digoxin pharmacokinetics.

MATERIALS AND METHODS

MDR1 genotypes for C3435T and G2677T/A SNPs were determined in 32 healthy subjects whose single oral dose digoxin pharmacokinetics had been measured over 48 h.

RESULTS

A significant relationship was observed between C3435T SNP and digoxin AUCs ( p<0,05). Homozygous TT subjects had 20% higher digoxin plasma concentrations than CT and CC subjects and a trend for higher 48 h digoxin urinary recoveries (TT>CT>CC). Similar results, although not statistically significant, were observed from the MDR1 G2677T/A SNP.

CONCLUSIONS

Our results confirm that the MDR1 C3435T single nucleotide polymorphism (SNP) significantly affects digoxin disposition kinetics, with homozygous TT subjects presenting the highest plasma concentrations.

摘要

背景

外显子26中MDR1基因C3435T单核苷酸多态性(SNP)对洋地黄毒苷药代动力学的影响最近受到了质疑。目的:阐明外显子26(C3435T)和21(G2677T/A)中MDR1基因多态性与洋地黄毒苷药代动力学之间的关系。

材料与方法

对32名健康受试者测定了C3435T和G2677T/A SNP的MDR1基因型,这些受试者单次口服洋地黄毒苷的药代动力学在48小时内进行了测量。

结果

观察到C3435T SNP与洋地黄毒苷的AUC之间存在显著关系(p<0.05)。纯合子TT受试者的洋地黄毒苷血浆浓度比CT和CC受试者高20%,并且48小时洋地黄毒苷尿回收率有升高趋势(TT>CT>CC)。从MDR1 G2677T/A SNP观察到类似结果,尽管无统计学意义。

结论

我们的结果证实,MDR1基因C3435T单核苷酸多态性(SNP)显著影响洋地黄毒苷处置动力学,纯合子TT受试者的血浆浓度最高。

相似文献

1
Digoxin pharmacokinetics and MDR1 genetic polymorphisms.地高辛药代动力学与多药耐药基因1(MDR1)基因多态性
Eur J Clin Pharmacol. 2003 Apr;58(12):809-12. doi: 10.1007/s00228-003-0567-5. Epub 2003 Mar 1.
2
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.MDR1基因的2677A等位基因变体影响非索非那定的处置。
Clin Pharmacol Ther. 2004 Nov;76(5):418-27. doi: 10.1016/j.clpt.2004.08.002.
3
Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.MDR1基因C3435T多态性对地高辛药代动力学及MDR1基因表达影响的Meta分析
Br J Clin Pharmacol. 2005 Aug;60(2):159-71. doi: 10.1111/j.1365-2125.2005.02392.x.
4
Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.双嘧达莫通过抑制P-糖蛋白增强地高辛的生物利用度。
Clin Pharmacol Ther. 2003 Jan;73(1):51-60. doi: 10.1067/mcp.2003.8.
5
Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers.源自C1236T、G2677T/A和C3435T的MDR1单倍型对健康中国志愿者单剂量口服地高辛药代动力学的影响。
Pharmacology. 2008;82(3):221-7. doi: 10.1159/000156488. Epub 2008 Sep 23.
6
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.P-糖蛋白MDR1基因单倍型对洋地黄毒苷稳态动力学的调节作用。
Clin Pharmacol Ther. 2002 Nov;72(5):584-94. doi: 10.1067/mcp.2002.129196.
7
Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.通过模型底物地高辛估计的人肠道P-糖蛋白活性。
Scand J Clin Lab Invest. 2007;67(2):123-34. doi: 10.1080/00365510600986084.
8
MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males.多药耐药基因1(MDR1)基因型不影响健康中国汉族男性单次口服600毫克伐昔洛韦的吸收。
Br J Clin Pharmacol. 2008 Aug;66(2):247-54. doi: 10.1111/j.1365-2125.2008.03189.x. Epub 2008 May 6.
9
No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.多药耐药蛋白1(MDR1)C3435T变异对洛哌丁胺的处置及中枢神经系统效应无影响。
Clin Pharmacol Ther. 2003 Nov;74(5):487-98. doi: 10.1016/S0009-9236(03)00234-0.
10
Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates.亚洲人群中C3435T单核苷酸MDR1基因多态性的频率:表型-基因型相关性
Br J Clin Pharmacol. 2003 Jul;56(1):78-83. doi: 10.1046/j.1365-2125.2003.01820.x.

引用本文的文献

1
Plasma lipidomic analysis to investigate putative biomarkers of P-glycoprotein activity in healthy volunteers.采用血浆脂质组学分析方法研究健康志愿者体内 P-糖蛋白活性的潜在生物标志物。
Clin Transl Sci. 2023 Oct;16(10):1935-1946. doi: 10.1111/cts.13601. Epub 2023 Aug 2.
2
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records.基于剂量记录的 ANRS 134-COPHAR 3 试验中患者体内替诺福韦和恩曲他滨及其细胞内代谢物的药代动力学模型。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0233918. doi: 10.1128/aac.02339-18. Epub 2023 Apr 26.
3

本文引用的文献

1
Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.双嘧达莫通过抑制P-糖蛋白增强地高辛的生物利用度。
Clin Pharmacol Ther. 2003 Jan;73(1):51-60. doi: 10.1067/mcp.2003.8.
2
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.P-糖蛋白MDR1基因单倍型对洋地黄毒苷稳态动力学的调节作用。
Clin Pharmacol Ther. 2002 Nov;72(5):584-94. doi: 10.1067/mcp.2002.129196.
3
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
弥漫性大 B 细胞淋巴瘤患者的候选胚系生物标志物与来那度胺疗效相关:意大利淋巴瘤基金会 MCL0208 试验。
Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504.
4
Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.采用 HPLC-MS/MS 技术对胎儿心动过速孕妇进行胎盘内治疗药物监测。
Int J Mol Sci. 2023 Jan 17;24(3):1848. doi: 10.3390/ijms24031848.
5
Common SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject.常见单核苷酸多态性C3435T可能会影响达格列净在健康受试者中的全身暴露量。
Transl Clin Pharmacol. 2022 Dec;30(4):212-225. doi: 10.12793/tcp.2022.30.e23. Epub 2022 Dec 26.
6
Pharmacogenomics Informs Cardiovascular Pharmacotherapy.药物基因组学指导心血管药物治疗。
Methods Mol Biol. 2022;2547:201-240. doi: 10.1007/978-1-0716-2573-6_9.
7
Combinations of common SNPs of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxin.转运体基因 ABCB1 的常见 SNPs 组合影响地高辛的口服表观生物利用度,但不影响其肾清除率。
Sci Rep. 2020 Jul 27;10(1):12457. doi: 10.1038/s41598-020-69326-y.
8
Impact of reduced P-glycoprotein function on digoxin concentrations in patients with dementia.减少 P-糖蛋白功能对痴呆症患者地高辛浓度的影响。
Br J Clin Pharmacol. 2019 Oct;85(10):2351-2359. doi: 10.1111/bcp.14049. Epub 2019 Aug 19.
9
Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma.ABCB1 多态性对多发性骨髓瘤患者来那度胺药代动力学和毒性的影响。
Med Oncol. 2019 May 14;36(6):55. doi: 10.1007/s12032-019-1280-2.
10
Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach.优化地高辛剂量:机器学习方法的应用。
J Healthc Eng. 2018 Aug 19;2018:3948245. doi: 10.1155/2018/3948245. eCollection 2018.
人多药耐药基因1(MDR1)多态性在P-糖蛋白底物地高辛的生物利用度及相互作用中的作用
Clin Pharmacol Ther. 2002 Aug;72(2):209-19. doi: 10.1067/mcp.2002.126177.
4
Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.胡椒碱是黑胡椒的主要成分,可抑制人类P-糖蛋白和CYP3A4。
J Pharmacol Exp Ther. 2002 Aug;302(2):645-50. doi: 10.1124/jpet.102.034728.
5
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.MDR1基因多态性与P-糖蛋白底物非索非那定的处置
Br J Clin Pharmacol. 2002 May;53(5):526-34. doi: 10.1046/j.1365-2125.2002.01591.x.
6
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.果汁会抑制有机阴离子转运多肽介导的药物摄取,从而降低非索非那定的口服生物利用度。
Clin Pharmacol Ther. 2002 Jan;71(1):11-20. doi: 10.1067/mcp.2002.121152.
7
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.携带多药耐药转运蛋白1等位基因变异的HIV-1感染者对抗逆转录病毒治疗的反应:一项药物遗传学研究。
Lancet. 2002 Jan 5;359(9300):30-6. doi: 10.1016/S0140-6736(02)07276-8.
8
MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.健康日本受试者单次口服给药后地高辛的MDR1基因型相关药代动力学
Pharm Res. 2001 Oct;18(10):1400-4. doi: 10.1023/a:1012244520615.
9
Effect of grapefruit juice on digoxin pharmacokinetics in humans.葡萄柚汁对人体地高辛药代动力学的影响。
Clin Pharmacol Ther. 2001 Oct;70(4):311-6.
10
Identification of functionally variant MDR1 alleles among European Americans and African Americans.在欧裔美国人和非裔美国人中鉴定功能变异的多药耐药基因1(MDR1)等位基因。
Clin Pharmacol Ther. 2001 Aug;70(2):189-99. doi: 10.1067/mcp.2001.117412.